Literature DB >> 29741114

Interval colorectal cancer: a challenging field in colorectal cancer.

Shi-Hao Dong1,2, Jiong-Qiang Huang1, Jing-Song Chen1.   

Abstract

Accumulated evidence has shown that colonoscopy may not be a perfect tool in screening and reducing the incidence of the colorectal cancer (CRC), because interval CRC (I-CRC), a specific subgroup of CRCs, has been challenging the traditional detection technology in recent years. I-CRC is accounting for an increasing proportion in CRCs. However, the effective procedures to prevent and supervise I-CRC need to be explored. In this review, we summarized the incidence, causes, risk factors, characteristics and management of I-CRC. It would promote the awareness of the special value in the education and training for the gastroenterologists, which plays an important role in conquering CRC.

Entities:  

Keywords:  colonoscopy; interval colorectal cancer; subgroup

Mesh:

Year:  2018        PMID: 29741114     DOI: 10.2217/fon-2017-0439

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  4 in total

1.  Clinical and endoscopic characteristics of sessile serrated adenomas/polyps with dysplasia/adenocarcinoma in a Korean population: A Korean Association for the Study of Intestinal Diseases (KASID) multicenter study.

Authors:  Ki-Hyun Kim; Kyeong-Ok Kim; Yunho Jung; Jun Lee; Sang-Wook Kim; Jae-Hyun Kim; Tae-Jun Kim; Young-Seok Cho; Young-Eun Joo
Journal:  Sci Rep       Date:  2019-03-08       Impact factor: 4.379

Review 2.  Colorectal Adenomas-Genetics and Searching for New Molecular Screening Biomarkers.

Authors:  Anna Siskova; Klara Cervena; Jan Kral; Tomas Hucl; Pavel Vodicka; Veronika Vymetalkova
Journal:  Int J Mol Sci       Date:  2020-05-05       Impact factor: 5.923

3.  Integrated Imaging Methodology Detects Claudin-1 Expression in Premalignant Nonpolypoid and Polypoid Colonic Epithelium in Mice.

Authors:  Fa Wang; Xiyu Duan; Jing Chen; Zhenghong Gao; Juan Zhou; Xiaoli Wu; Tse-Shao Chang; Miki Lee; Gaoming Li; Asma Nusrat; Rork Kuick; Henry D Appelman; Thomas D Wang
Journal:  Clin Transl Gastroenterol       Date:  2020-01       Impact factor: 4.396

4.  Taraxasterol acetate targets RNF31 to inhibit RNF31/p53 axis-driven cell proliferation in colorectal cancer.

Authors:  Chao-Tao Tang; Jing Yang; Zi-De Liu; Youxiang Chen; Chunyan Zeng
Journal:  Cell Death Discov       Date:  2021-04-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.